Meet us at

04 Mar
ADAS3D Medical selected as one of the 25 companies leaders in Cardiac Imaging in 2020. The magazine Cardiology 2.0 has included our company in this prestigious list because we are at the forefront of technological innovations in the evolving cardiac imaging space. In addition, describes us as "the new imaging friend for the electrophysiologist". If you want to read the full article, click on this text!
18 Feb
Galgo Medical receives FDA 510(k) Clearance of its software ADAS 3D. Galgo Medical announces US. Food and Drug Administration (FDA) 510(k) clearance of the software ADAS 3D that helps cardiologists, electrophysiologist, radiologists and technicians to visualize fribrosis, wall thickness and surrounding anatomical structures of the heart. The software is indicated for the use in the clinical setting to support the visualization and analysis of cardiac MR and CTA images for patients with cardiovascular disease.
07 Feb
Cicle Cardiovascular Imaging Inc. announces distribution and joint development with Galgo Medical SL to expand accessibility and use of cardiac MR to electrophysiology procedures. Circle Cardiovascular Imaging Inc. and Galgo Medical announced an agreement for distribution and joint development with respect to MRI scanner application products and workflows, with corresponding post-processing capabilities.
20 May
Publications. The article "Scar characterization to predict life-threateninG Arrhythmic events and sudden cardIac death in Cardiac Resynchronization Therapy patients. The GAUDI-CRT study" by the Hospital Clinic Barcelona team lead by Dr. Berruezo has been accepted for publication by the prestigious Journal of the American College of Cardiology.
10 March
ADAS 3D receives CE certification. ADAS 3D LV Software receives CE marking approval, Annex II according to directive 93/42/EEC Medical Device.
08 Feb
New users. Galgo Medical signs a collaboration agreement with the Hospital of the University of Pennsylvania to evaluate ADAS.
14 Jan
Jacobo Gil de Biedma joins Galgo as Director of Business Development. Galgo Medical recently named Mr Jacobo Gil de Biedma as its new Director of Business Development.
20 Oct
Inveready enters the capital of Galgo Medical. The venture capital firm Inveready participates in a round of 1million Euros for the medical software company Galgo Medical to move forward with its development and marketing efforts of its three product lines.
06 ​​Mar
Galgo, Clínic, UPF & UB signed a collaboration agreement for cardiac arrhthmia development. Hospital Clínic de Barcelona, Universitat Pompeu Fabra (UPF) and Universitat de Barcelona (UB) signed a collaboration agreement with Galgo Medical SL for the development of technologies to identify the cause of cardiac arrhythmias and facilitate their treatment.
25 Feb
SYLVIUS Project Collaboration Agreement with IMIM signed. Institut Hospital del Mar d’Investigacions Biomèdiques (IMIM) signed a collaboration agreement with Galgo Medical SL for the development of the project SYLVIUS for the development of software tools to predict language function for optimal surgical strategy.
15 Jun
French CIR qualification granted. Galgo Medical obtained the CIR qualification granted by the French Administration in recognition as an intensive research and development (R&D) SME. The qualification is granted for a period of two years.

Legal | Privacy Policy | Cookie Policy